· The approval is based on two placebo-controlled phase 3 studies, which showed mepolizumab significantly reduced the annualised rate of moderate/severe exacerbations and time to first moderate/severe ...

Darcy joined C+D as a senior reporter in August 2025. She has been a journalist for several years, writing news and features across a range of areas, including healthcare and the pharmaceutical ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has today approved Kostaive (zapomeran) mRNA COVID-19 vaccine, for the immunization of individuals aged 18 years of age and older.

MHRA says buying from illegal online sellers can put health at real risk amid booming black market Losing weight may be a common new year resolution but health experts have warned against buying ...

Send this article to your social connections.

ABSTRACT: Botswana has traditionally relied on its mining sector, particularly diamond exports, as the primary driver of economic growth. However, this reliance exposes the country to risks associated ...

The U.K. Medicines and Healthcare Products Regulatory Agency has laid out an approach to medical products for rare diseases, which the agency said afflict 3.5 million U.K. citizens. One of the ...

The Web Guide test uses Gemini to divide, curate, and explain your search results across AI-generated categories. The Web Guide test uses Gemini to divide, curate, and explain your search results ...

Beyond AI Overviews and AI Mode, Google is working on “Web Guide” to better organize Search results into categories with additional context and insights. Simply, “Web Guide groups web links in helpful ...

An adrenaline nasal spray for the emergency treatment of anaphylaxis has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA). This marks the first time a needle-free ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved serplulimab (Hetronifly, Henlius) to treat adults with extensive-stage small cell lung cancer (ES-SCLC). Serplulimab is the ...